Ligand Pharmaceuticals Incorporated
NASDAQ:LGND · NASDAQ Global Market
+$2.89 today
Vol 0.55M · Avg 0.22M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+139.07%
Period High
$274.88
Period Low
$112.56
Latest
$274.88
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Belite Bio, Inc
NASDAQ:BLTE
$5.96B
Praxis Precision Medicines, Inc.
NASDAQ:PRAX
$5.95B
Mirum Pharmaceuticals, Inc.
NASDAQ:MIRM
$5.32B
Crinetics Pharmaceuticals, Inc.
NASDAQ:CRNX
$3.76B
ACADIA Pharmaceuticals Inc.
NASDAQ:ACAD
$3.68B
Viking Therapeutics, Inc.
NASDAQ:VKTX
$3.62B
NewAmsterdam Pharma Company N.V.
NASDAQ:NAMS
$3.56B
Dyne Therapeutics, Inc.
NASDAQ:DYN
$3.27B
Soleno Therapeutics, Inc.
SLNO
$2.76B
ADMA Biologics, Inc.
NASDAQ:ADMA
$1.96B
What is the latest LGND filing?
The latest filing shown is 4 dated Jun 18, 2026.
How many recent filings does LGND have?
Intrinsic Alpha currently shows 20 recent filings for LGND.
Explore More
Continue the stock analysis
Jump to another research area for this company.